Merck & Co teams up with Parexel CRO on biosimilars for CTs
This article was originally published in Scrip
Executive Summary
Merck BioVentures, the biosimilars unit of Merck & Co, has teamed up with Parexel International for its consulting services and CRO capabilities – including exclusivity for certain candidates.